pravastatin has been researched along with Acute Disease in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.38) | 18.2507 |
| 2000's | 27 (84.38) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, IS; Apple, FS; Cannon, CM; Christenson, RH; Clopton, P; Daniels, LB; deFilippi, C; Diercks, DB; Hogan, CJ; Hollander, JE; Jaffe, AS; Limkakeng, A; Maisel, AS; Marston, NA; McCord, J; Mueller, C; Nagurney, J; Neath, SX; Nowak, RM; Peacock, WF; Schreiber, D; Shah, KS; Vilke, GM; Wu, AH | 1 |
| Hara, M; Hori, M; Komuro, I; Matsumoto, S; Matsumura, Y; Minamino, T; Mizuno, H; Nakatani, D; Nishino, M; Okuda, K; Ozaki, K; Sakata, Y; Sato, H; Shimizu, M; Suna, S; Takashima, S; Takeda, H; Tanaka, T; Usami, M | 1 |
| Kerensky, RA; Monroe, VS; Pepine, CJ; Rivera, E; Smith, KM | 1 |
| Anagnostopoulos, GK; Arvanitidis, D; Kostopoulos, P; Margantinis, G; Tsiakos, S | 1 |
| Averkov, OV; Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Vaulin, NA | 1 |
| Averkov, OV; Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Slavina, NN; Vaulin, NA | 1 |
| Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Rodis, FI; Tselepis, AD | 1 |
| Cannon, CP; Ray, KK | 1 |
| Braunwald, E; Cairns, R; Cannon, CP; Jackson, G; McCabe, CH; Ray, KK; Sacks, FM; Tonkin, AM | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Pfeffer, MA; Ray, KK; Wiviott, SD | 1 |
| Braunwald, E; Cairns, R; Cannon, CP; Gibson, CM; Kirtane, AJ; McCabe, CH; Morrow, DA; Ray, KK; Ridker, PM; Rifai, N; Skene, AM | 1 |
| Amyot, R; Arnold, M; Bonafede, N; Cannon, CP; Dupuis, J; Lonn, E; Ricci, J; Rouleau, JL; Roux, R; Tardif, JC; Title, LM; Woo, A | 1 |
| Maron, DJ | 1 |
| Armstrong, DF; Chan, P; Eagle, KA; Fang, J; Goldberg, AD; Kline-Rogers, E; Mukherjee, D; Nallamothu, BK; Patel, A; Rubenfire, M; Tsai, TT | 1 |
| Becker, C; Delmore, G; Hvalic, C; Krähenbühl, S; Schlienger, R | 1 |
| Braunwald, E; Cannon, CP; McCabe, CH; Morrow, DA; Murphy, SA; O'Donoghue, M; Sabatine, MS | 1 |
| Braunwald, E; Cannon, CP; Jarolim, P; McCabe, CH; Morrow, DA; Ray, KK; Sabatine, MS; Scirica, BM; Shui, A | 1 |
| Denton, M; Eckermann, S; Friedlander, D; Glasziou, P; Hunt, D; Kirby, A; Magnus, P; Mulray, S; Sallaberger, M; Simes, J; Tonkin, AM; White, H | 1 |
| Alberti, A; Bergamasco, L; Brscic, E; Celeste, A; De Bernardi, A; Formato, L; Fuster, V; Moretti, C; Pucci, A; Sheiban, I; Trevi, G | 1 |
| Pitchumoni, CS; Tsigrelis, C | 1 |
| Kirch, W; Matschke, K; Schindler, C; Thorns, M; Tugtekin, SM | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Shui, A | 1 |
| Auch, D; Kaps, M; Rosengarten, B | 1 |
| Balestrieri, GP; Cerudelli, B; Giustina, G; Marocolo, D; Scalvini, T; Sleiman, I | 1 |
| Catovsky, D; Clutterbuck, RD; Millar, JL; Newman, A; Powles, RL | 1 |
| Hartleb, M; Januszewski, K; Rymarczyk, G | 1 |
| Ersoy, FF; Süleymanlar, G; Tuncer, M; Yakupoğlu, G | 1 |
| Buckley, BM; Colwell, NS; Murphy, MB | 1 |
| Den Hartog, FR; Rila, H; Schaafsma, HJ; Van Kalmthout, PM; Van Loenhout, TT; Verheugt, FW | 1 |
| Choi-Kwon, S; Kim, JS | 1 |
| Gaw, A | 1 |
| Böhm, M; Hamm, CW; Heeschen, C; Laufs, U; Snapinn, S; White, HD | 1 |
5 review(s) available for pravastatin and Acute Disease
| Article | Year |
|---|---|
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; C-Reactive Protein; Coronary Artery Disease; Coronary Thrombosis; Disease Progression; Endothelium, Vascular; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Macrophages; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Randomized Controlled Trials as Topic; Secondary Prevention; Severity of Illness Index | 2003 |
Acute pancreatitis due to pravastatin therapy.
Topics: Acute Disease; Anticholesteremic Agents; Humans; Hypercholesterolemia; Male; Middle Aged; Pancreatitis; Pravastatin | 2003 |
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.
Topics: Acute Disease; Animals; Atorvastatin; Cholesterol; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; T-Lymphocytes | 2004 |
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.
Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome | 2006 |
Healthy ageing: addressing acute coronary syndrome?
Topics: Acute Disease; Adult; Age Factors; Aged; Aging; Australia; Coronary Disease; Endothelium, Vascular; Evidence-Based Medicine; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; New Zealand; Pravastatin; Risk Factors; Sex Factors; Simvastatin; Syndrome; United States | 2001 |
15 trial(s) available for pravastatin and Acute Disease
| Article | Year |
|---|---|
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
Topics: Acute Disease; Adrenomedullin; Aged; Biomarkers; Chest Pain; Emergency Service, Hospital; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Risk Assessment; Risk Factors; Severity of Illness Index | 2015 |
[Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Coronary Disease; Drug Administration Schedule; Electrocardiography; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Platelet Aggregation; Pravastatin; Pyrroles; Time Factors | 2003 |
[Non ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasis].
Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Electrocardiography; Female; Heptanoic Acids; Homeostasis; Humans; Male; Middle Aged; Pravastatin; Pyrroles; Syndrome; Time Factors | 2003 |
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; CD40 Ligand; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Stents; Ticlopidine; Treatment Outcome | 2004 |
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
Topics: Acute Disease; Angina, Unstable; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; Time Factors | 2005 |
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Topics: Acute Disease; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors; Syndrome | 2005 |
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).
Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pravastatin; Prognosis; Pyrroles; Syndrome; Ultrasonography; Vasodilation | 2005 |
Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
Topics: Acute Disease; Adult; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Incidence; Male; Myocardial Ischemia; Pravastatin; Risk Factors; Survival Rate; Treatment Outcome | 2004 |
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction)
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Disease; Atorvastatin; Coronary Disease; Double-Blind Method; Enzymes; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Pyrroles; Survival Analysis; Syndrome; Thrombolytic Therapy; Treatment Outcome | 2006 |
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Topics: Acute Disease; Adult; Age Factors; Aged; Angina, Unstable; Anticholesteremic Agents; Cost-Benefit Analysis; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Survival Rate; Syndrome | 2006 |
In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment.
Topics: Acute Disease; Aged; Angina, Unstable; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherectomy, Coronary; Atorvastatin; Coronary Artery Disease; Coronary Vessels; Female; Glycophorins; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunohistochemistry; Male; Middle Aged; Pravastatin; Pyrroles | 2007 |
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Topics: Acute Disease; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; Coronary Artery Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Monocytes; Neopterin; Pravastatin; Prognosis; Pyrroles; Risk Factors; Secondary Prevention; Survival Analysis | 2007 |
Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans.
Topics: Acute Disease; Adult; Anticholesteremic Agents; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Placebos; Pravastatin | 2007 |
Comparison of the effects of simvastatin and pravastatin on acute rejection episodes in renal transplant patients.
Topics: Acute Disease; Adult; Anticholesteremic Agents; Female; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Transplantation; Male; Middle Aged; Pravastatin; Prospective Studies; Simvastatin | 2000 |
Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial.
Topics: Acute Disease; Angina, Unstable; Anticholesteremic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Pravastatin; Survival Analysis; Treatment Outcome | 2001 |
12 other study(ies) available for pravastatin and Acute Disease
| Article | Year |
|---|---|
Decreased mortality associated with statin treatment in patients with acute myocardial infarction and lymphotoxin-alpha C804A polymorphism.
Topics: Acute Disease; Aged; Alleles; Animals; Cell Adhesion; Cell Movement; Endoplasmic Reticulum; Female; Follow-Up Studies; Heterozygote; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphotoxin-alpha; Male; Middle Aged; Myocardial Infarction; Myocytes, Cardiac; Polymorphism, Single Nucleotide; Pravastatin; Proportional Hazards Models; Rats; Vascular Cell Adhesion Molecule-1 | 2013 |
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
Topics: Acute Disease; Angina, Unstable; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome | 2005 |
Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein
Topics: Acute Disease; Anticholesteremic Agents; Biomarkers; Cholesterol, LDL; Coronary Disease; Follow-Up Studies; Humans; Michigan; Phenalenes; Pravastatin; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2005 |
[Recurrent acute pancreatitis during pravastatin-therapy].
Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pancreatitis; Pravastatin; Recurrence; Time Factors | 2006 |
Pravastatin: a potential cause for acute pancreatitis.
Topics: Acute Disease; Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Middle Aged; Pancreatitis; Pravastatin | 2006 |
Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
Topics: Acute Disease; Aged; Creatine Kinase; Dyspnea; Heart Transplantation; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Cells; Pravastatin; Probability; Rhabdomyolysis; Time Factors | 2007 |
Pravastatin-associated myopathy. Report of a case.
Topics: Acute Disease; Aged; Biopsy; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Hypertension; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pravastatin | 1995 |
A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Enzyme Inhibitors; Hematopoietic Stem Cells; HL-60 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid; Lovastatin; Pravastatin; Simvastatin | 1997 |
Acute cholestatic hepatitis associated with pravastatin.
Topics: Acute Disease; Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Male; Middle Aged; Pravastatin | 1999 |
Unstable angina pectoris.
Topics: Acute Disease; Angina, Unstable; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Risk Factors | 2000 |
Poststroke emotional incontinence and decreased sexual activity.
Topics: Acute Disease; Affective Symptoms; Chronic Disease; Crying; Female; Follow-Up Studies; Humans; Laughter; Libido; Male; Middle Aged; Pravastatin; Recovery of Function; Sexual Behavior; Sexual Dysfunction, Physiological; Stroke | 2002 |
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States | 2002 |